DEN-induced HCC resulted in significant upregulation of the mRNA levels of the pro-inflammatory markers TNFα, CCR2, CCL2 and VCAM-1 (the latter two only in respectively the preventive and therapeutic group), and, in most settings, this was most pronounced in mice treated with HIF-1α ASO. This evidence concerns the gene CCL2 and hepatocellular carcinoma.